Klaus Bartosch is CEO, Founder and Managing Partner of Dreamoro Group, bringing together Dreamoro Ventures and Dreamoro Studio to back and build early-stage healthtech companies. He works alongside founders on investment readiness, product development and commercialisation, with a focus on prevention, early intervention and capital-efficient growth.
He is also Chairman of CardiAction and CardiAction Screening Australia, supporting the commercialisation and delivery of cardiovascular screening through community pharmacies. This work grounds his investment perspective in the practical challenges of healthcare adoption and building sustainable business models.
Klaus previously co-founded 1st Group, the company behind MyHealth1st, led its ASX IPO in 2015 and served as CEO and Managing Director until 2022. During his tenure, its platforms engaged 18 million consumers and thousands of healthcare businesses, and the company was the market leader in the allied health, pharmacy and specialist markets. He subsequently founded Dreamoro to bring healthtech founders real operator experience and deep sector expertise.
With more than 35 years in technology, Klaus brings a founder-and-investor perspective on what makes digital health worth backing, and how AI is changing the economics of building and scaling healthcare businesses.
